Evidence for human immunodeficiency virus type 1 replication in vivo in CD14+ monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy

Journal of Virology

Volumn 76, Issue 2, 2002, Pages 707-716

  Zhu, T ^a   Muthui, D ^a   Holte, S ^a   Nickle, D ^a   Feng, F ^a   Brodie, S ^a   Hwangbo, Y ^a   Mullins, J I ^a   Corey, L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; INDINAVIR; LAMIVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; MALE; MONOCYTE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; T LYMPHOCYTE; UNINDEXED SEQUENCE; VIREMIA; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; ANTIGENS, CD14; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; HALF-LIFE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MOLECULAR SEQUENCE DATA; MONOCYTES; ORGAN SPECIFICITY; PHYLOGENY; PROVIRUSES; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRION; VIRUS REPLICATION;

EID: 0036138852     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.2.707-716.2002     Document Type: Article

References (66)

1. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes
2. Clinical implications of HIV dynamics and drug resistance in macrophages
3. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS
4. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection
5. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death
6. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
7. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
8. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
9. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
10. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
11. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1): Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types
12. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
13. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene
14. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
15. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
16. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy
17. The role of mononuclear phagocytes in HTLV-III/LAV infection
18. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
19. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy
20. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
21. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
22. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
23. Infection of monocyte/macrophages by human T lymphotropic virus type III
24. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
25. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
26. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy
27. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
28. Mononuclear phagocytes of blood and bone marrow: Comparative roles as viral reservoirs in human immunodeficiency virus type 1 infection
29. Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients
30. Kinetics of human monocytopoiesis
31. Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins
32. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
33. HIV-1 replication in patients with undetectable plasma virus receiving HAART
34. Macrophages as a source of HIV during opportunistic infections
35. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
36. Decay characteristics of HIV-1-infected compartments during combination therapy
37. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
38. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus
39. MODELTEST: Testing the model of DNA substitution
40. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
41. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)
42. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays
43. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
44. The neighbor-joining method: A new method for reconstructing phylogenetic trees
45. HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS
46. Biological and virologic characteristics of primary HIV infection
47. Mechanisms of immune activation of human immunodeficiency virus in monocytes/macrophages
48. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection
49. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
50. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine
51. Endotoxin administration to humans primes alveolar macrophages for increased production of inflammatory mediators
52. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes
53. Monocytes harbor replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy
54. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
55. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
56. Origin and turnover of monocytes and macrophages
57. Viral dynamics in human immunodeficiency virus type 1 infection
58. Observations on human monocyte kinetics after pulse labeling
59. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
60. Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection
61. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
62. Genetic characterization of rebounding HIV-1 after cessation of highly active anti-retroviral therapy
63. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
64. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells
65. Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: Evidence for viral compartmentalization and selection during sexual transmission